BEDMINSTER, N.J., Feb. 22 /PRNewswire-FirstCall/ -- Bioject Medical
Technologies Inc., (Nasdaq: BJCT), a leading developer of needle-free drug
delivery systems, announced today that the Company will report its financial
results for the fourth quarter ended December 31, 2004 on Monday, February 28,
2005, after the close of the financial markets. Management will conduct a
conference call on Tuesday, March 1, 2005, at 10:00 a.m. Eastern Time to
review the results for the quarter and the year. Jim O'Shea, Chairman,
President, and CEO, and John Gandolfo, Chief Financial Officer, will be
hosting the call.
Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to investors, members of the news media and
the general public. To participate in the call via telephone, please dial
1-877-258-8079, or to access the call live over the Internet, visit Bioject's
website at http://www.bioject.com and click on the Investor Relations section, then
on the event icon. A conference call replay will also be available until
March 8 2005. To listen to the replay, please dial 1-877-660-6853, replay
account number 7303, identification number 140533.
Bioject Medical Technologies Inc., based in Bedminster, New Jersey, with
operations in Portland, Oregon, is an innovative developer and manufacturer of
needle-free drug delivery systems. Needle-free injection works by forcing
medication at high speed through a tiny orifice held against the skin. This
creates a fine stream of high-pressure fluid penetrating the skin and
depositing medication in the tissue beneath. The Company is focused on
developing mutually beneficial agreements with leading pharmaceutical,
biotechnology, and veterinary companies.
For more information about Bioject, visit: http://www.bioject.com.
SOURCE Bioject Medical Technologies Inc.
 back to top
Related links:
http://www.bioject.com
CONTACT:
John Gandolfo, Chief Financial Officer of
Bioject Medical Technologies Inc., +1-908-470-2800, ext. 5102
|
